Coronavirus: Morocco buys a whole stock of chloroquine drugs

Text by: RFI Follow

While several countries, including France, consider the tests carried out with chloroquine on patients with Covid-19 encouraging, the Moroccan government bought the stocks of Nivaquine, an antimalarial drug produced on the basis of chloriquine by the French group Sanofi.

Publicity

Is chloroquine the new weapon against Covid-19? The Moroccan government is convinced of this, while French researchers are still in the testing phase. The Moroccan Ministry of Health has just bought from the French laboratory Sanofi the entire stock of Nivaquine, a drug based on chloroquine, produced in its factories in Casablanca.

Sanofi Maroc has confirmed to RFI the operation, the very same operation, since it is accompanied by an additional order. As of Wednesday, the Moroccan Prime Minister on his Twitter account said that all Covid-19 patients would be treated with Plaquenil, a drug also made from chloroquine.

According to the online site Yabiladi , following information on the tests carried out in France, the Moroccans had already rushed on the stocks of Plaquenil in pharmacies.

Read also: Against the coronavirus, the effectiveness of an antimalarial drug in question

The fact remains that Nivaquine purchased by the Moroccan state was intended for export to South Saharan Africa. But in this regard, Sanofi tells us that it continues to produce and export another antimalarial, ASAQ based on artemisinin sold in thirty countries of the continent and for which no stock shortage is to be feared .

Newsletter With the Daily Newsletter, find the headlines directly in your mailbox

Download the app

• Morocco
• Coronavirus
• Health and Medicine